Neuralink, Elon Musk's brain implant venture, is reaching out to major U.S. neurosurgery centers to potentially begin testing its devices on humans, according to a Reuters report. Before that can happen though, the U.S. government needs to grant the company approval, which is far from certain. In 2022, the U.S. Food and Drug Administration rejected its application to proceed with human trials due to safety concerns. Neuralink has been working to address those concerns ever since. 

Share:
More In Science
Earth in Danger Zone in Nearly All Ecological Ways, Study Says
Earth has pushed past seven out of eight scientifically established safety limits and into “the danger zone,” not just for an overheating planet that's losing its natural areas, but for the well-being of people living on it, according to a new study.
Load More